SPARC Expression Did Not Predict Efficacy of nab-Paclitaxel Plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial
Hidalgo, M., Plaza, C., Musteanu, M., Illei, P., Brachmann, C. B., Heise, C., Pierce, D. W., Lopez-Casas, P. P., Menendez, C., Tabernero, J., Romano, A., Wei, X., Lopez-Rios, F., Von Hoff, D. D.Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-14-3222
Date:
July, 2015
File:
PDF, 1.48 MB
english, 2015
File converter
More search results
More benefits 
